Nuvalent, Inc. (NUVL) Analyst Forecast

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$98.24
Day's range
$102.98

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
06/10/2026 Guggenheim Brad Canino $124.00 $123.25   0.61%
06/10/2026 UBS David Dai $124.00 $123.25   0.61%
06/09/2026 Wells Fargo Eva Fortea Verdejo $124.00 $122.88   0.91%
06/03/2026 Leerink Partners Andrew Berens $165.00 $91.35   80.62%
11/17/2025 Barclays Etzer Darout $152.00 $108.00   40.74%
10/31/2025 UBS David Dai $132.00 $98.17   34.46%
10/27/2025 Piper Sandler Kelsey Goodwin $128.00 $93.39   37.06%
10/15/2025 Cantor Fitzgerald Josh Schimmer $135.00 $89.35   51.1%
06/24/2025 H.C. Wainwright Swayampakula Ramakanth $130.00 $76.88   69.09%
11/13/2024 BMO Capital Etzer Darout $134.00 $69.99   91.46%
10/23/2024 UBS David Dai $100.00 $93.71   6.71%
09/16/2024 Guggenheim Kelsey Goodwin $105.00 $110.25   -4.76%
09/16/2024 Stifel Nicolaus Bradley Canino $135.00 $87.45   54.37%
09/16/2024 Raymond James Christopher Raymond $100.00 $87.45   14.35%
07/10/2024 Stifel Nicolaus Bradley Canino $115.00 $73.63   56.19%
04/16/2024 Jefferies Roger Song $97.00 $64.75   49.81%
04/01/2024 Leerink Partners Christopher Liu $110.00 $75.09   46.49%

Nuvalent Inc FAQ's

Nuvalent Inc has been rated by research analysts at Guggenheim, UBS, Truist Financial, Barclays, Robert W. Baird, Stifel Nicolaus in the past 90 days.